XML 20 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 793.4 $ 824.0 $ 2,485.0 $ 2,371.2
Cost of sales 443.8 442.2 1,374.9 1,290.0
Gross profit 349.6 381.8 1,110.1 1,081.2
Selling, general and administrative expenses 165.9 161.9 529.9 483.7
Restructuring expenses and asset impairments 4.1 17.7 8.2 21.1
Operating income 179.6 202.2 572.0 576.4
Gain on sale of business (93.8) (34.8) (93.8) (34.8)
Other (income) expense - net (2.1) (1.0) 5.6 (3.3)
Interest expense 13.7 9.6 40.1 28.6
Income before income taxes 261.8 228.4 620.1 585.9
Provision for income taxes 52.8 49.7 132.8 129.2
Net income 209.0 178.7 487.3 456.7
Net loss attributable to noncontrolling interest 0.1 0.0 0.2 0.2
Net income attributable to IDEX $ 209.1 $ 178.7 $ 487.5 $ 456.9
Earnings per common share:        
Basic earnings per common share attributable to IDEX (in dollars per share) $ 2.76 $ 2.37 $ 6.44 $ 6.02
Diluted earnings per common share attributable to IDEX (in dollars per share) $ 2.75 $ 2.36 $ 6.42 $ 6.00
Share data:        
Basic weighted average common shares outstanding (in shares) 75.6 75.4 75.6 75.8
Diluted weighted average common shares outstanding (in shares) 75.9 75.8 75.9 76.1